Tempus AI announced a multi-year collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine. This partnership aims to harness AI for rapid discovery and innovation in Alzheimer's disease research.
The collaboration will leverage Tempus’s AI-powered data analytics platform, Lens, to analyze and restructure the Center’s repository of genomic data. Together, the teams will work to uncover genomic patterns that can advance the understanding of Alzheimer’s disease, investigate affected gene and cell types, and enable the development of new therapeutics.
By harnessing Lens’s advanced AI capabilities, the collaboration aims to generate actionable insights that drive the discovery of targeted therapies and accelerate the creation of novel clinical applications. This initiative represents a significant expansion of Tempus's AI applications into a major neurological disease area.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.